BlackRock
TBIO

BlackRock’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

BlackRock’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,379
Closed -$10.9K – 5371
2024
Q1 		$10.9K Sell
1,379
-58
-4% -$436 ﹤0.01% 5078
2023
Q4 		$10.3K Sell
1,437
-16
-1% -$178 ﹤0.01% 5142
2023
Q3 		$27.2K Sell
1,453
-59
-4% -$1.44K ﹤0.01% 5100
2023
Q2 		$43K Buy
1,512
+140
+10% +$5.59K ﹤0.01% 5089
2023
Q1 		$76.6K Sell
1,372
-173
-11% -$6.13K ﹤0.01% 5031
2022
Q4 		$33.4K Sell
1,545
-4,020
-72% -$109K ﹤0.01% 5309
2022
Q3 		$166K Sell
5,565
-119
-2% -$4.19K ﹤0.01% 5025
2022
Q2 		$184K Sell
5,684
-20,455
-78% -$1.41M ﹤0.01% 5060
2022
Q1 		$2.53M Sell
26,139
-755
-3% -$114K ﹤0.01% 4290
2021
Q4 		$5.23M Buy
26,894
+8,368
+45% +$1.3M ﹤0.01% 3980
2021
Q3 		$3.71M Buy
18,526
+7,417
+67% +$1.88M ﹤0.01% 4055
2021
Q2 		$4.4M Buy
+11,109
New +$3.93M ﹤0.01% 3928

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock's TBIO Position: Q2 2024 in Review

BlackRock sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 1,379 shares — an estimated $10.9K sold.

BlackRock first reported a position in TBIO in Q2 2021 and held it in 12 quarters. The position peaked at $5.23M in Q4 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

  • BlackRock reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 1,379 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $10.9K.
  • BlackRock first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • BlackRock's Telesis Bio, Inc. Common Stock position peaked at $5.23M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.